Hahn & Co to buy scandal-stricken Namyang Dairy Products PE firm to buy 53% of dairy product maker for $278 mln
Translated by Kim So-in 공개 2021-05-31 07:33:37
이 기사는 2021년 05월 31일 07:14 thebell 에 표출된 기사입니다.
South Korean private equity (PE) firm Hahn & Co will buy a controlling stake in scandal-ridden Namyang Dairy Products.Hahn & Co will acquire around 53% of the dairy product maker including 51.68% owned by Namyang's ex-chairman Hong Won-sik, 0.89% owned by Hong’s wife and 0.07% owned by his grandson, for 310.7 billion won ($278 million). Hong’s younger brother Myeong-sik will remain a minority shareholder with a 0.45% stake.
Given the small deal size, the PE firm plans to finance the acquisition through its third blind-pool fund, which closed at 3.8 trillion won in 2019, without using acquisition financing.
Namyang and Hahn & Co didn’t even hire financial advisors to close the deal swiftly. The two companies hired local law firm Kim & Chang as their representative after completing the basic due diligence. Hahn & Co plans to conduct detailed due diligence next, but it is unlikely to take long as Kospi-listed Namyang has simple business structure, industry sources said.
The deal came after Namyang was put under public criticism for claiming that its yogurt drink helps prevent the Covid-19.
Hong offered to resign from the top post earlier this month and vowed to end dynastic control over the family-owned dairy product maker. An emergency committee forced Hong’s mother and his eldest son out of the board.
Hahn & Co plans to introduce an executive officer system to enhance transparency in corporate governance and management efficiency. The PE firm also introduced the system to its portfolio companies including SsangYong C&E and Hanon Systems. (Reporting by Si-eun Park)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
best clicks
최신뉴스 in 전체기사
-
- '(여자)아이들+나우어데이즈+우기' 큐브엔터 IP 라인업 확대
- 광동제약, 30억 출자 KD헬스바이오 6개월만에 청산
- [바이오텍 CFO 스토리]CFO는 재무만? 에이비엘의 이재천, BD까지 '전천후'
- [루키 바이오텍 in market]'세번 실패 없다' 셀비온의 도전, '데이터·실적' 선뵌다
- 디앤디파마텍, IPO 신고서 '4차정정'에서도 '멧세라'
- 시노펙스, 대형 스마트 FPCB 모듈 공장 준공
- 대양엔바이오, '초순수용 활성탄' 정부 지원사업 선정
- [LK삼양 뉴비기닝]성장 키워드 '동남아·4대 신사업'
- [이통3사 AI 매치업]sLLM 경쟁, SKT '선착' KT '추격' LGU+ '후발'
- 삼성SDS, 아마존 출신 잇단 영입 '글로벌 공략 속도'